Vanguard Group Inc Co Diagnostics, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,778,182 shares of CODX stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,778,182
Previous 1,781,283
0.17%
Holding current value
$1.24 Million
Previous $2.23 Million
40.12%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CODX
# of Institutions
45Shares Held
5.59MCall Options Held
67.5KPut Options Held
174K-
Private Advisory Group LLC Redmond, WA1.18MShares$827,1430.1% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny556KShares$388,9350.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$351,4170.0% of portfolio
-
Geode Capital Management, LLC Boston, MA346KShares$241,8570.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$191,0300.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $23.6M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...